siRNA therapy reduces triglycerides in clients along with rare ailment

.RESEARCH STUDY HIGHLIGHT.19 September 2024.

Plozasiran decreased triglyceride levels through 80% as well as reduced the threat of pancreatitis in individuals with consistent chylomicronemia, with or without a genetic medical diagnosis.